Comorbidities and malignancies negatively affect survival in myelodysplastic syndromes: a population-based study

Population-based studies that contain detailed clinical data on patients with myelodysplastic syndrome (MDS) are scarce. This study focused on the real-world overall survival (OS) of MDS patients in association with comorbidities, specifically malignancies. An observational population-based study us...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood Adv
Autors principals: Rozema, Johanne, Hoogendoorn, Mels, Kibbelaar, Robby, van den Berg, Eva, Veeger, Nic, van Roon, Eric
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2021
Matèries:
Health Services and Outcomes
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7948295/
https://ncbi.nlm.nih.gov/pubmed/33656535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020003381
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars